NASDAQ:GERN
Geron Corporation Stock News
$3.73
-0.200 (-5.09%)
At Close: May 06, 2024
Top Myths About Penny Stocks Debunked
11:32am, Sunday, 14'th May 2023
Debunking the most popular myths about penny stocks The post Top Myths About Penny Stocks Debunked appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that five abstracts related to imetelstat, a first-in-class tel
Geron to Announce First Quarter 2023 Financial Results on May 11, 2023
04:30pm, Thursday, 04'th May 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2023 financial results o
Why Shares of Geron Are Up 30% This Week
12:18pm, Thursday, 20'th Apr 2023
Geron's imetelstat has shown promise to treat a rare blood disorder. The drug could have wide oncology applications.
Geron to Present at Upcoming Investor Conferences in April
04:40pm, Wednesday, 12'th Apr 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron's Chairman and Chief Executi
Geron Corporation (GERN) Q4 2022 Earnings Call Transcript
08:53pm, Thursday, 16'th Mar 2023
Geron Corporation (NASDAQ:GERN ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Aron Feingold - Vice President, Investor Relations and Corporate Communications John Sc
Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates
07:05pm, Thursday, 16'th Mar 2023
Geron (GERN) delivered earnings and revenue surprises of 9.09% and 11.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
04:30pm, Thursday, 09'th Mar 2023
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its fourth quarter and full-year 2022 fina
Choosing Penny Stocks for Short Term Trading; 3 Tips
06:00am, Tuesday, 21'st Feb 2023
Use these tips for trading penny stocks in the short term The post Choosing Penny Stocks for Short Term Trading; 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks
2 Top Healthcare Stocks to Buy Right Now
09:37am, Monday, 13'th Feb 2023
One has a breakout drug, the other a nice-sized moat.
4 Penny Stocks To Buy According To Analysts & Targets Over 600%
09:33am, Wednesday, 25'th Jan 2023
Analysts have put these on their list of penny stocks to buy. Do you agree?
Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference
07:30am, Thursday, 12'th Jan 2023
FOSTER CITY, Calif.--( BUSINESS WIRE )--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron's Chairman and Chief Execu
Geron's Data Allows Development Of Several Catalysts
07:01pm, Monday, 09'th Jan 2023
Primary endpoint of 8-week transfusion independence met in the phase 3 IMerge study; Imetelstat was used as a monotherapy to treat patients with lower-risk myelodysplastic syndrome. Regulatory applica
How to Start Investing in Penny Stocks in 2023
11:00am, Sunday, 08'th Jan 2023
Are you using these tips for investing in penny stocks? The post How to Start Investing in Penny Stocks in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Geron (GERN) Up on Imetelstat Data on Myelodysplastic Syndromes
03:48pm, Thursday, 05'th Jan 2023
Geron (GERN) posts positive top-line data from the phase III IMerge study investigating its lead candidate, imetelstat for treating lower risk myelodysplastic syndromes. Shares up.
